115480 — CU Medical Systems Balance Sheet
0.000.00%
- KR₩38bn
- KR₩53bn
- KR₩41bn
- 22
- 82
- 13
- 31
Annual balance sheet for CU Medical Systems, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,011 | 11,845 | 7,035 | 9,872 | 22,270 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 24,795 | 29,371 | 10,539 | 13,599 | 12,633 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 47,088 | 53,591 | 31,235 | 34,426 | 40,221 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,985 | 13,444 | 25,632 | 30,650 | 26,360 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 81,660 | 72,841 | 88,412 | 85,650 | 103,569 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 30,375 | 16,404 | 10,831 | 27,504 | 11,151 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 39,803 | 23,951 | 29,717 | 31,906 | 44,827 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 41,857 | 48,890 | 58,695 | 53,745 | 58,742 |
Total Liabilities & Shareholders' Equity | 81,660 | 72,841 | 88,412 | 85,650 | 103,569 |
Total Common Shares Outstanding |